Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
Journal of Neurology, Neurosurgery and Psychiatry
, cilt.93, sa.12, ss.1322-1329, 2022 (SCI-Expanded)
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry
, cilt.87, sa.12, ss.1343-1349, 2016 (SCI-Expanded)
Prolonged cerebellar ataxia associated with lithium-valproic acid intoxication
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY
, cilt.13, sa.2, ss.166, 2012 (SCI-Expanded)
Frontal functions in young patients with essential tremor: A case comparison study
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
, cilt.18, sa.1, ss.64-72, 2006 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
Lityum-valproik asit zehirlenmesi sonrasında ortaya çıkan uzun süreli serebellar ataksi
Anadolu Psikiyatri Dergisi
, cilt.2, sa.13, ss.166, 2012 (Hakemli Dergi)
Statinlerin Nöroloji Pratiğindeki Yeri
Deneysel ve Klinik Tıp Dergisi
, cilt.26, sa.2, ss.55-61, 2009 (Scopus)
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar
A Multi-Country Comparative Effectiveness Study of Dimethyl Fumarate and Non-Specific Immunosuppressants in a Real-World Setting: Evidence from MSBase
Pan-Asian Committee on Treatment and Research in Multiple Sclerosis (PACTRIMS), Perth, Avustralya, 23 - 25 Kasım 2022
Description of Multiple Sclerosis cohorts from the Middle East between 2009 and 2019
MS Australia Progress in MS Research Scientific Conference, Hobart, Avustralya, 4 - 05 Nisan 2022, ss.17-18
Early Predictors of Disability in Paediatric Multiple Sclerosis: Evidence from a Multi -National Registry
Annual Meeting of the American-Academy-of-Neurology, Washington, Amerika Birleşik Devletleri, 2 - 07 Nisan 2022
Efficacy and Safety of Eculizumab in Patients with Neuromyelitis Optica Spectrum Disorder Previously Treated with Rituximab: Findings from the Phase 3 PREVENT Study
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94
Impact of Eculizumab on Health Outcomes in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Findings from the PREVENT Study
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94
Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: the Phase 3 PREVENT Study
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94
Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94
Benefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: Findings from the Phase 3 PREVENT Study
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94
Impact of Eculizumab on Disability Worsening and Quality of Life in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Results from the Phase 3 PREVENT Study
Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94
Subgroup analyses from the Phase 3 PREVENT study in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.289-290
Personalizing treatment effect based on patient's baseline profile: a statistical modelling approach applied to randomized clinical trial and observational study data
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.788-790
Impact of eculizumab on disability measures in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: phase 3 PREVENT study
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.737-738
A multicenter international study to evaluate different aspects of relationship between MS and pregnancy
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.176-177
Impact of eculizumab on reported quality of life in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from the PREVENT study
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.294-295
Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.870
Impact of eculizumab on hospitalization rates and relapse treatment in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from the phase 3 PREVENT study
35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.288-289
Mortality in Multiple Sclerosis
10th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Ho Chi Minh City, Vietnam, 23 - 25 Kasım 2017, cilt.24, ss.383
Tumor Necrosis Factor Alpha and Beta Receptor Gene Polymorphism in Multiple Sclerosis Patients
Forum of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), California, Amerika Birleşik Devletleri, 1 - 03 Şubat 2018, cilt.24, ss.62
Susac syndrome: clinical features, laboratory testing and treatment responses of 20 cases
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.90-91
Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.327-328
Frequency of cognitive impairment in relapsing-remitting multiple sclerosis patients in Turkey and affecting factors
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.458-459
Methylprednisolone concentrations in breast milk and serum in patients with multiple sclerosis treated with IV pulse methylprednisolone
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, Fransa, 25 - 28 Ekim 2017, cilt.23, ss.462
Defining secondary progressive multiple sclerosis
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 7 - 10 Ekim 2015, cilt.21, ss.798-800
Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, İspanya, 7 - 10 Ekim 2015, cilt.21, ss.308-310
Neuromyelitis optica and neuromyelitis optica spectrum disorder patients in Turkish cohort: demographic, clinical, laboratory and radiological features
Joint ACTRIMS-ECTRIMS Meeting, Massachusetts, Amerika Birleşik Devletleri, 10 - 13 Eylül 2014, cilt.20, ss.348-349
Clinical And Radiological Characteristics Of Tumefactive Demyelinating Lesions: Follow-up Study
5th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Beijing, Çin, 13 - 15 Eylül 2012, cilt.19, ss.656
NMO-spectrum disorders in Turkish population: Clinical, demographic characteristics and the presence of NMO-Ig G
11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.27
A comparative study of evoked potentials and EMG in Turkish patients with Multiple Sclerosis and Neurobehcet's Syndrome
11th International Congress on Neuromuscular Diseases, İstanbul, Türkiye, 2 - 07 Temmuz 2006, cilt.16
Cognitive impairment in fibromyalgia patients without depression
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.346
Kitap & Kitap Bölümleri
Metrikler
BM Sürdürülebilir Kalkınma Amaçları
